Dipyridamole
- 14 May 1987
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 316 (20) , 1247-1257
- https://doi.org/10.1056/nejm198705143162005
Abstract
DIPYRIDAMOLE (2,6-bis-diethanolamino-4,8-dipiperidinopyrimido-(5,4-d)-pyrimidine) is a pyrimidopyrimidine derivative that is among the 50 most commonly prescribed drugs in the United States.1 This review will focus on the mechanisms of action of dipyridamole and the rationale provided by clinical trials of its pharmacology for its use as an orally administered antiplatelet drug in humans.Mechanism of Action as an Antithrombotic DrugThe mechanism of action of dipyridamole as an antithrombotic drug in vivo has been a subject of controversy. Indeed, in experimental models in which the drug has been shown to prevent thrombosis, it is possible that factors other than platelet . . .Keywords
This publication has 76 references indexed in Scilit:
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Membranoproliferative GlomerulonephritisNew England Journal of Medicine, 1984
- Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic DeathNew England Journal of Medicine, 1984
- Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass OperationsNew England Journal of Medicine, 1984
- Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.Circulation, 1983
- Failure of Antiplatelet and Anticoagulant Therapy to Improve Patency of Grafts after Coronary-Artery BypassNew England Journal of Medicine, 1979
- A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened StrokeNew England Journal of Medicine, 1978
- Relative potencies of dipyridamole and related agents as inhibitors of cyclic nucleotide phosphodiesterases: Possible explanation of mechanism of inhibition of platelet functionLife Sciences, 1975
- Activation and inhibition of blood platelet adenylate cyclase by adenosine or by 2-chloroadenosineLife Sciences, 1972
- Platelet aggregation I. Regulation by cyclic AMP and prostaglandin E1Biochemical and Biophysical Research Communications, 1969